1. Home
  2. BHB vs PHAR Comparison

BHB vs PHAR Comparison

Compare BHB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHB
  • PHAR
  • Stock Information
  • Founded
  • BHB 1887
  • PHAR 1988
  • Country
  • BHB United States
  • PHAR Netherlands
  • Employees
  • BHB N/A
  • PHAR N/A
  • Industry
  • BHB Major Banks
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHB Finance
  • PHAR Health Care
  • Exchange
  • BHB Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • BHB 558.4M
  • PHAR 627.5M
  • IPO Year
  • BHB 1997
  • PHAR N/A
  • Fundamental
  • Price
  • BHB $34.14
  • PHAR $8.80
  • Analyst Decision
  • BHB Hold
  • PHAR Strong Buy
  • Analyst Count
  • BHB 2
  • PHAR 3
  • Target Price
  • BHB $33.50
  • PHAR $27.00
  • AVG Volume (30 Days)
  • BHB 31.4K
  • PHAR 7.3K
  • Earning Date
  • BHB 01-21-2025
  • PHAR 10-24-2024
  • Dividend Yield
  • BHB 3.49%
  • PHAR N/A
  • EPS Growth
  • BHB N/A
  • PHAR N/A
  • EPS
  • BHB 2.78
  • PHAR N/A
  • Revenue
  • BHB $148,706,000.00
  • PHAR $285,745,000.00
  • Revenue This Year
  • BHB N/A
  • PHAR $20.89
  • Revenue Next Year
  • BHB $3.78
  • PHAR $11.15
  • P/E Ratio
  • BHB $12.37
  • PHAR N/A
  • Revenue Growth
  • BHB N/A
  • PHAR 30.64
  • 52 Week Low
  • BHB $23.26
  • PHAR $6.65
  • 52 Week High
  • BHB $38.47
  • PHAR $13.20
  • Technical
  • Relative Strength Index (RSI)
  • BHB 43.48
  • PHAR 58.84
  • Support Level
  • BHB $33.88
  • PHAR $8.71
  • Resistance Level
  • BHB $36.00
  • PHAR $9.59
  • Average True Range (ATR)
  • BHB 0.99
  • PHAR 0.36
  • MACD
  • BHB -0.29
  • PHAR 0.16
  • Stochastic Oscillator
  • BHB 12.79
  • PHAR 64.73

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Share on Social Networks: